Edward L. Coles

Array ( [id] => 2936259 [patent_doc_number] => 05190862 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-03-02 [patent_title] => 'Chromogenic compounds and the use thereof as enzyme substrates' [patent_app_type] => 1 [patent_app_number] => 7/776590 [patent_app_country] => US [patent_app_date] => 1991-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12539 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 260 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/190/05190862.pdf [firstpage_image] =>[orig_patent_app_number] => 776590 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2958851 [patent_doc_number] => 05198419 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-03-30 [patent_title] => 'Formulated medicines for enhancing the efficacy of beta-lactam antibiotics in prophylaxis and treatment against infectious disease due to pathogenic bacteria' [patent_app_type] => 1 [patent_app_number] => 7/769766 [patent_app_country] => US [patent_app_date] => 1991-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5404 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/198/05198419.pdf [firstpage_image] =>[orig_patent_app_number] => 769766 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2890801 [patent_doc_number] => 05177001 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-01-05 [patent_title] => 'In vitro enzymatic conversion of glycosylated mammalian vitamin D-binding protein to a potent macrophage activating factor' [patent_app_type] => 1 [patent_app_number] => 7/767742 [patent_app_country] => US [patent_app_date] => 1991-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5171 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/177/05177001.pdf [firstpage_image] =>[orig_patent_app_number] => 767742 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2836677 [patent_doc_number] => 05171569 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-12-15 [patent_title] => 'Factor IX preparations uncontaminated by plasma components or pox virus' [patent_app_type] => 1 [patent_app_number] => 7/764073 [patent_app_country] => US [patent_app_date] => 1991-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 9509 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 131 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/171/05171569.pdf [firstpage_image] =>[orig_patent_app_number] => 764073 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3462943 [patent_doc_number] => 05391712 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-02-21 [patent_title] => 'Non-hemolytic streptolysin O variants' [patent_app_type] => 1 [patent_app_number] => 7/752428 [patent_app_country] => US [patent_app_date] => 1991-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 15869 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/391/05391712.pdf [firstpage_image] =>[orig_patent_app_number] => 752428 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3589381 [patent_doc_number] => 05585344 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-17 [patent_title] => 'Liver-derived receptors for advanced glycosylation endproducts and uses thereof' [patent_app_type] => 1 [patent_app_number] => 7/749438 [patent_app_country] => US [patent_app_date] => 1991-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 18 [patent_no_of_words] => 14833 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/585/05585344.pdf [firstpage_image] =>[orig_patent_app_number] => 749438 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3409508 [patent_doc_number] => 05437976 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-08-01 [patent_title] => 'Multi-domain DNA ligands bound to a solid matrix for protein and nucleic acid affinity chromatography and processing of solid-phase DNA' [patent_app_type] => 1 [patent_app_number] => 7/742856 [patent_app_country] => US [patent_app_date] => 1991-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5302 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 135 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/437/05437976.pdf [firstpage_image] =>[orig_patent_app_number] => 742856 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3092861 [patent_doc_number] => 05298399 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-03-29 [patent_title] => 'Gene and process for producing a thermostable urease' [patent_app_type] => 1 [patent_app_number] => 7/732242 [patent_app_country] => US [patent_app_date] => 1991-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7891 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/298/05298399.pdf [firstpage_image] =>[orig_patent_app_number] => 732242 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3868184 [patent_doc_number] => 05763197 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-09 [patent_title] => 'Human hematopoietic stem cell' [patent_app_type] => 1 [patent_app_number] => 7/720883 [patent_app_country] => US [patent_app_date] => 1991-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8974 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 146 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/763/05763197.pdf [firstpage_image] =>[orig_patent_app_number] => 720883 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2950114 [patent_doc_number] => 05221611 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-06-22 [patent_title] => 'ddI immunoassays, derivatives, conjugates and antibodies' [patent_app_type] => 1 [patent_app_number] => 7/717614 [patent_app_country] => US [patent_app_date] => 1991-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12359 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/221/05221611.pdf [firstpage_image] =>[orig_patent_app_number] => 717614 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2803818 [patent_doc_number] => 05124437 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-06-23 [patent_title] => 'Galactosamine substitute of poly-.omega.-substituted-L-glutamic acid (or aspartic acid)' [patent_app_type] => 1 [patent_app_number] => 7/690496 [patent_app_country] => US [patent_app_date] => 1991-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 2883 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/124/05124437.pdf [firstpage_image] =>[orig_patent_app_number] => 690496 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2951149 [patent_doc_number] => 05221665 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-06-22 [patent_title] => 'N-substituted amides' [patent_app_type] => 1 [patent_app_number] => 7/686918 [patent_app_country] => US [patent_app_date] => 1991-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 15428 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/221/05221665.pdf [firstpage_image] =>[orig_patent_app_number] => 686918 [rel_patent_id] =>[rel_patent_doc_number] =>)